Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connolly

Showing results (311-320 of 380) with videos related to

Pageof 38
Sort By:
The British Journal of Surgery|October 25, 2021
Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failureThomas Niederwieser, Eva Braunwarth, Bobby V M Dasari, et al.
European Journal of Immunology|May 29, 2008
Systemic IFN-alpha drives kidney nephritis in B6.Sle123 miceAnna-Marie Fairhurst, Alexis Mathian, John E Connolly, et al.
Cancer Research Communications|July 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer StudySamantha I Liang, Zoe Quandt, Sara Wienke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2012
B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone miceSun-Hee Hwang, Huiyin Lee, Miwako Yamamoto, et al.
Arthritis Research & Therapy|April 22, 2023
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb studyPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Open Forum Infectious Diseases|July 27, 2023
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)Michael G Ison, Debra F Weinstein, Marta Dobryanska, et al.
The Science of the Total Environment|October 15, 2023
Advancing the community health vulnerability index for wildland fire smoke exposureJihoon Jung, Joseph L Wilkins, Claire L Schollaert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2019
Enhancing Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells by Recruiting the Intracellular Fc Receptor TRIM21Patricia M L Ng, Nivashini Kaliaperumal, Chia Yin Lee, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin betaLi-Zhen He, Venky Ramakrishna, John E Connolly, et al.
Pageof 38

Showing results (311-320 of 380) with videos related to

Sort By:
Pageof 38
The British Journal of Surgery|October 25, 2021
Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failureThomas Niederwieser, Eva Braunwarth, Bobby V M Dasari, et al.
European Journal of Immunology|May 29, 2008
Systemic IFN-alpha drives kidney nephritis in B6.Sle123 miceAnna-Marie Fairhurst, Alexis Mathian, John E Connolly, et al.
Cancer Research Communications|July 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer StudySamantha I Liang, Zoe Quandt, Sara Wienke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2012
B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone miceSun-Hee Hwang, Huiyin Lee, Miwako Yamamoto, et al.
Arthritis Research & Therapy|April 22, 2023
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb studyPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Open Forum Infectious Diseases|July 27, 2023
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)Michael G Ison, Debra F Weinstein, Marta Dobryanska, et al.
The Science of the Total Environment|October 15, 2023
Advancing the community health vulnerability index for wildland fire smoke exposureJihoon Jung, Joseph L Wilkins, Claire L Schollaert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2019
Enhancing Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells by Recruiting the Intracellular Fc Receptor TRIM21Patricia M L Ng, Nivashini Kaliaperumal, Chia Yin Lee, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin betaLi-Zhen He, Venky Ramakrishna, John E Connolly, et al.
Pageof 38